We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
mRNA developer Moderna and computer giant IBM have announced an agreement under which Moderna will explore next-generation technologies, including quantum computing and artificial intelligence (AI), to accelerate mRNA research and science. Read More
Wirelessly connected infusion pumps, nurse call systems and medication dispensing systems are highly vulnerable to malicious activity, according to new research by security company Armis.
Roche has teamed up with Eli Lilly to develop Roche’s Elecsys Amyloid Plasma Panel (EAPP), an investigational blood-based biomarker test designed to give patients an earlier Alzheimer’s disease diagnosis. Read More
Theravance Biopharma and Viatris have alleged that multiple competitors infringed on patent protections for Yupelri (revefenacin) — a combination drug-device product used to treat chronic obstructive pulmonary disease (COPD) — by developing generic versions.
New York, N.Y.-based cardiac artificial intelligence (AI) company Cleerly has partnered with ClearDATA, a data security company headquartered in Austin, Texas, to protect health data collected as part of Cleerly’s coronary analysis studies.
Insulet has completed two asset purchases that should about double the Massachusetts-based company’s portfolio of pump and automated insulin delivery (AID) technologies.